Clinical Pharmacists Role in the Management of Hypertension in Jordan
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Background: studies have demonstrated the crucial role of clinical pharmacists as integrated part of heath care team. Not only in Jordan but also in the Middle East region, clinical pharmacy practice is not well established. This current study is the first to evaluate physicians - pharmacists' collaborative approach to uncontrolled blood pressure in Jordan and the Middle East.
| Condition | Intervention |
|---|---|
|
Hypertension |
Other: pharmaceutical care services |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Health Services Research |
| Official Title: | Clinical Pharmacists Role in the Management of Hypertension in Jordan |
- percentage of patients who achieved blood pressure goals specified by the JNC VII at each group [ Time Frame: 6 month ] [ Designated as safety issue: No ]defined a goal to be achieved if the systolic blood pressure fell below 140 mm Hg and the diastolic blood pressure fell below 90 mm Hg. Or systolic blood pressure fell below 130 mm Hg and the diastolic blood pressure fell below 80 mm Hg if patient was diabetic.
- mean reductions in both systolic and diastolic blood pressure readings [ Time Frame: 6 months ] [ Designated as safety issue: No ]mean reductions in systolic blood pressure (Systolic blood pressure at enrollment - Systolic blood pressure last follow up visit) and diastolic BP (Diastolic blood pressure at enrollment - Diastolic blood pressure last follow up visit) for both study groups
| Enrollment: | 266 |
| Study Start Date: | March 2009 |
| Study Completion Date: | November 2009 |
| Primary Completion Date: | November 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: intervention group
physician-pharmacist teamwork
|
Other: pharmaceutical care services
Patients treatment related problems and therapeutic needs or complains identified by clinical pharmacist and managed collaboratively by both pharmacist and the physician.
|
|
No Intervention: control
physician only team
|
Detailed Description:
Objective: this study aimed to evaluate clinical pharmacists' role in the management of uncontrolled hypertensive patients in Jordan. Design: single blinded randomized controlled clinical trial. Patients: 253 patients with uncontrolled hypertension specified as higher blood pressure readings than the recommended goals by the seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure (JNC VII) at the time of enrollment.
Interventions: patients were randomly allocated to an intervention or control group: 130 and 123 patients, respectively. Patients in both arms were followed up for 6 months. In the intervention group, patients were managed by physician-clinical pharmacist team. In the control group, patients were managed by physician(s) only and were not provided pharmaceutical care services.
Eligibility| Ages Eligible for Study: | 21 Years to 88 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients with uncontrolled BP, receiving 0-3 antihypertensive drugs with no change in the regimen or dose within the past 3 month.
Exclusion Criteria:
- Patients with hypertensive urgency or emergency with BP more than (180/110).
- Patients with recent stroke or myocardial infraction (within past 6 months).
- Patients with Class III or IV Chronic heart Failure (CHF).
- Patients with Unstable angina.
- Patients with Serious renal or hepatic disease.
- Pregnant patients.
- Patients with Dementia or cognitive impairment.
- If the patient is unable to provide informed written consent.
Contacts and Locations| Jordan | |
| family medicine clinic JUH | |
| Amman, Jordan, 13046 | |
| Principal Investigator: | Eman Hammad, MSc | University of Jordan/ Faculty of Pharmacy |
| Study Director: | Abla Al bsoul, PhD | University of Jordan/ Faculty of Pharmacy |
More Information
No publications provided
| Responsible Party: | Eman Hammad, faculty of pharmacy / University of Jordan |
| ClinicalTrials.gov Identifier: | NCT01079494 History of Changes |
| Other Study ID Numbers: | JU8071383 |
| Study First Received: | March 2, 2010 |
| Last Updated: | April 6, 2010 |
| Health Authority: | Jordan: Ethical Committee |
Keywords provided by University of Jordan:
|
Uncontrolled blood pressure |
Additional relevant MeSH terms:
|
Hypertension Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 22, 2013